• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. ACTIVA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. ACTIVA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR Back to Search Results
Model Number 37612
Device Problems Delayed Charge Time (2586); Charging Problem (2892); Communication or Transmission Problem (2896)
Patient Problems Erythema (1840); Irritation (1941); Pain (1994); Therapeutic Effects, Unexpected (2099)
Event Date 02/24/2020
Event Type  malfunction  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received from a consumer regarding a patient who was implanted with an implantable neurostimulator (ins).It was reported that the patient charged for the first time in february and the second time last night.Both times, the patient felt a pulse going from the ins recharger (insr) into her chest.It was not painful but felt like a throbbing/pulsing sensation, which did not feel good.The patient also said it took too long to charge the ins.The first time they charged, they waited for an hour and a half and the charging percentage barely moved.The second charging time, the patient charged for 2.5 hours and it only increased 25% with 8 coupling bars.The patient was advised to contact a rep and to try charging more frequently.No further complications were reported/anticipated.
 
Event Description
Information was received from a healthcare provider (hcp), via the manufacturer¿s representative (rep), who reported the patient was implanted in (b)(6) of 2020.After the device was turned on, they began charging and experienced redness and irritation at the incision site.In addition, the patient had never been able to get above 50% charged and felt a ¿radiating sensation¿ when they charged, in particular at the juncture of the extension and the implantable neurostimulator (ins).There were no factors that could have led or contributed to this.In march the patient went to the emergency room (er) where they were checked for an infection and was found not to have one.The patient was checked again in april or may for an infection and was told again they did not have an infection.The manufacturer¿s representative(rep) facilitated getting the patient a new recharger to see if that was the issue, but it didn¿t resolve any of the issues.The patient was told to try to put a towel between the recharger and their skin, but couldn¿t get a good enough connection, so it didn¿t work.The patient also always wore a t-shirt when charging, but that didn¿t help either.The issue was not currently resolved, and the hcp didn¿t have any further information.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received stating that the patient was not able to get above 50% battery level, since implant.Further discussion revealed that the patient has difficulty with tolerating recharging for a long period of time.Patient skin gets red, and it's painful when she recharges.She has been checked by 2 different hospitals for infection.Patient said issue has been going on since february.Patient recharges 3-4 times a week from 15-45 minutes.It was reviewed with the patient that it can take little over 4 hours to recharge from empty to full, the fact that she hasn't been able to recharge anymore than 1.5-2 hours since implant means that it would be difficulty to get beyond 50% ins battery level, especially since she can't tolerate recharging more than 45 minutes at best, now.It was suggested putting another layer of clothing to help with sensitivity since patient is getting 8 coupling bars.Suggested perhaps recharging more frequently than now with shorter sessions to help with sensitivity.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACTIVA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
MDR Report Key9865154
MDR Text Key184449364
Report Number3004209178-2020-05902
Device Sequence Number1
Product Code MHY
UDI-Device Identifier00763000100360
UDI-Public00763000100360
Combination Product (y/n)N
PMA/PMN Number
P960009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Type of Report Initial,Followup,Followup
Report Date 09/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/28/2020
Device Model Number37612
Device Catalogue Number37612
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/19/2020
Initial Date FDA Received03/23/2020
Supplement Dates Manufacturer Received09/01/2020
09/10/2020
Supplement Dates FDA Received09/02/2020
09/11/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age41 YR
-
-